|
Volumn 19, Issue 5, 2002, Pages 928-935
|
What is the optimal treatment strategy for chronic obstructive pulmonary disease exacerbations?
a a a a a |
Author keywords
Aerosols; Chronic obstructive pulmonary disease; Corticosteroids; Exacerbation; Metered dose inhaler bronchodilators; Treatment
|
Indexed keywords
BRONCHODILATING AGENT;
FENOTEROL;
IPRATROPIUM BROMIDE;
MEPREDNISONE;
METHYLPREDNISOLONE;
SALBUTAMOL;
STEROID;
GLUCOCORTICOID;
ADULT;
AGED;
ARTICLE;
CHRONIC OBSTRUCTIVE LUNG DISEASE;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DISEASE EXACERBATION;
DYSPNEA;
FEMALE;
FORCED EXPIRATORY VOLUME;
HOSPITALIZATION;
HUMAN;
LENGTH OF STAY;
MALE;
METERED DOSE INHALER;
PATIENT SATISFACTION;
PRIORITY JOURNAL;
QUESTIONNAIRE;
RISK;
SCORING SYSTEM;
TREATMENT OUTCOME;
ACUTE DISEASE;
COMPARATIVE STUDY;
HOSPITAL READMISSION;
PROSPECTIVE STUDY;
QUALITY OF LIFE;
RANDOMIZED CONTROLLED TRIAL;
SPIROMETRY;
TREATMENT FAILURE;
ACUTE DISEASE;
AGED;
ALBUTEROL;
BRONCHODILATOR AGENTS;
COMPARATIVE STUDY;
DYSPNEA;
FEMALE;
FENOTEROL;
GLUCOCORTICOIDS, SYNTHETIC;
HUMAN;
IPRATROPIUM;
MALE;
METERED DOSE INHALERS;
METHYLPREDNISOLONE;
PATIENT READMISSION;
PATIENT SATISFACTION;
PROSPECTIVE STUDIES;
PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;
QUALITY OF LIFE;
SPIROMETRY;
SUPPORT, NON-U.S. GOV'T;
TREATMENT FAILURE;
GLUCOCORTICOIDS;
HUMANS;
|
EID: 0036014546
PISSN: 09031936
EISSN: None
Source Type: Journal
DOI: 10.1183/09031936.02.00268702 Document Type: Article |
Times cited : (18)
|
References (28)
|